Agomelatine in the treatment of social anxiety disorder
- PMID: 20637821
- DOI: 10.1016/j.pnpbp.2010.07.007
Agomelatine in the treatment of social anxiety disorder
Similar articles
-
Agomelatine in the treatment of mood and anxiety disorders.Br J Hosp Med (Lond). 2010 Mar;71(3):153-6. doi: 10.12968/hmed.2010.71.3.46979. Br J Hosp Med (Lond). 2010. PMID: 20220721
-
A case of obsessive-compulsive disorder successfully treated with agomelatine monotherapy.J Clin Psychopharmacol. 2012 Apr;32(2):289-90. doi: 10.1097/JCP.0b013e318249298c. J Clin Psychopharmacol. 2012. PMID: 22388158 No abstract available.
-
Efficacy of agomelatine in generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.J Clin Psychopharmacol. 2008 Oct;28(5):561-6. doi: 10.1097/JCP.0b013e318184ff5b. J Clin Psychopharmacol. 2008. PMID: 18794654 Clinical Trial.
-
Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):885-92. doi: 10.1517/17425255.2014.907794. Epub 2014 Apr 9. Expert Opin Drug Metab Toxicol. 2014. PMID: 24717138 Review.
-
[Agomelatine].Med Monatsschr Pharm. 2009 Aug;32(8):282-8. Med Monatsschr Pharm. 2009. PMID: 19777735 Review. German.
Cited by
-
Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study.Neuropsychiatr Dis Treat. 2013;9:243-51. doi: 10.2147/NDT.S41557. Epub 2013 Feb 15. Neuropsychiatr Dis Treat. 2013. PMID: 23430979 Free PMC article.
-
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression.Int J Mol Sci. 2015 Jan 5;16(1):1111-30. doi: 10.3390/ijms16011111. Int J Mol Sci. 2015. PMID: 25569089 Free PMC article. Review.
-
Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series.Ann Gen Psychiatry. 2011 Feb 28;10(1):5. doi: 10.1186/1744-859X-10-5. Ann Gen Psychiatry. 2011. PMID: 21356085 Free PMC article.
-
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.Oxid Med Cell Longev. 2016;2016:3472032. doi: 10.1155/2016/3472032. Epub 2016 Oct 18. Oxid Med Cell Longev. 2016. PMID: 27829983 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical